BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16766376)

  • 21. The prognosis of pulmonary arterial hypertension associated with primary Sjögren's syndrome: a cohort study.
    Liu Z; Yang X; Tian Z; Qian J; Wang Q; Zhao J; Huang C; Liu Y; Guo X; Wang H; Lai J; Li M; Zhao Y; Zeng X
    Lupus; 2018 Jun; 27(7):1072-1080. PubMed ID: 29419347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and risk factors for pulmonary arterial hypertension associated with primary Sjögren's syndrome: 15 new cases from a single center.
    Zhang N; Zhao Y; Wang H; Sun W; Chen M; Fan Q; Yang Z; Wei W
    Int J Rheum Dis; 2019 Sep; 22(9):1775-1781. PubMed ID: 31368254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension.
    Hamaguchi Y; Fujimoto M; Hasegawa M; Matsushita T; Takehara K
    J Dermatol Sci; 2009 Jul; 55(1):66-7. PubMed ID: 19342201
    [No Abstract]   [Full Text] [Related]  

  • 24. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjögren's syndrome.
    Yan S; Li M; Wang H; Yang X; Zhao J; Wang Q; Liu Y; Lai J; Tian Z; Song H; Zhao Y; Zeng X
    Int J Rheum Dis; 2018 May; 21(5):1068-1075. PubMed ID: 29624870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endothelin].
    Maeda S; Miyauchi T; Goto K
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():112-6. PubMed ID: 16895176
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombotic microangiopathic nephropathy, pulmonary hypertension and nephromegaly: case report of a patient treated with endothelin receptor antagonist.
    Losito A; Pittavini L; Covarelli C
    Clin Nephrol; 2012 Feb; 77(2):164-70. PubMed ID: 22257549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PAH and many other indications. Old and new endothelin receptor antagonists.].
    Schmitz J; Holzgrabe U
    Pharm Unserer Zeit; 2010 Nov; 39(6):430-5. PubMed ID: 20967930
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bosentan for treatment of heart failure].
    Yoshimoto T; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():159-63. PubMed ID: 17571378
    [No Abstract]   [Full Text] [Related]  

  • 29. [Young patient with stress dyspnea of uncertain origin. Evaluate for pulmonary hypertension!].
    MMW Fortschr Med; 2002 Oct; 144(42):64. PubMed ID: 12534004
    [No Abstract]   [Full Text] [Related]  

  • 30. Just another case of Sjogren's syndrome?
    Lard LR; Huizinga TW
    J Rheumatol; 2010 Jun; 37(6):1363. PubMed ID: 20516046
    [No Abstract]   [Full Text] [Related]  

  • 31. Withdrawal of epoprostenol therapy in a patient with pulmonary hypertension associated with Sjögren's syndrome.
    Fujita T; Tanabe N; Kasahara Y; Sugiura T; Sakao S; Tatsumi K
    Intern Med; 2014; 53(19):2237-40. PubMed ID: 25274237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined endothelin receptor antagonist and transcatheter interventional therapy of patent ductus arteriosus with severe pulmonary artery hypertension.
    Ussia GP; Mulè M; Caruso E; Aiello R; Tamburino C
    Int J Cardiol; 2007 Apr; 116(3):427-9. PubMed ID: 16875749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term remission of pulmonary veno-occlusive disease associated with primary Sjögren's syndrome following immunosuppressive therapy.
    Naniwa T; Takeda Y
    Mod Rheumatol; 2011 Dec; 21(6):637-40. PubMed ID: 21394665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal pulmonary hypertension in primary Sjøgren's syndrome.
    Aslaksen HK; Nossent HC
    Clin Exp Rheumatol; 2004; 22(4):507. PubMed ID: 15301259
    [No Abstract]   [Full Text] [Related]  

  • 35. Bosentan for chronic thromboembolic pulmonary hypertension.
    Confalonieri M; Kodric M; Longo C; Vassallo FG
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1503-12. PubMed ID: 19954311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of persistent pulmonary hypertension of the newborn with bosentan.
    Nakwan N; Choksuchat D; Saksawad R; Thammachote P; Nakwan N
    Acta Paediatr; 2009 Oct; 98(10):1683-5. PubMed ID: 19523174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of sensorineural hearing loss in Sjögren's syndrome with corticosteroid.
    Kim KS; Kim HS
    Korean J Intern Med; 2016 May; 31(3):612-5. PubMed ID: 27055663
    [No Abstract]   [Full Text] [Related]  

  • 38. [Bosentan].
    Taéron C
    Rev Infirm; 2005 Feb; (108):33-4. PubMed ID: 15816717
    [No Abstract]   [Full Text] [Related]  

  • 39. Recovery from pulmonary hypertension with steroid therapy in a patient with Sjögren's syndrome and polymyositis.
    Mariette X; Brenot F; Brouet JC
    J Rheumatol; 1994 Apr; 21(4):772-3. PubMed ID: 8035412
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
    Akpek EK; Lindsley KB; Adyanthaya RS; Swamy R; Baer AN; McDonnell PJ
    Ophthalmology; 2011 Jul; 118(7):1242-52. PubMed ID: 21459453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.